×

Cancer drug shows promise

1:17 PM ET Mon, 2 March 2015

Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.